Managing Director, Transaction Advisory
CurrentAndrew is a Managing Director with 16 years of finance and accounting experience, with the last 13 years focusing on buy-side and sell-side due diligence transactions in the middle market (up to $1B). He specializes in quality of revenue analyses, proof of cash assistance, cash to accrual conversion, and working capital projections / negotiations.Averaging more than 40 deals a year, Andrew’s industry experience is more than one or two deals, but rather a portfolio of transactions in each industry. Within healthcare, Andrew’s recent transactions include leading deal teams in the following subsectors: dermatology, eye care, dental, pain management, home health, home infusion, acute & urgent care facilities, behavioral health, medical supplies, nurse staffing, and physical & speech therapy. While his healthcare experience is deep, Andrew’s exposure to a wide range of industries allows him to bring unique perspectives on deal issues that may arise. As it relates to specific experience on sell-side diligence, prior to joining BRG, Andrew worked at a national, financial service advisory / investment banking firm, completing sell-side diligence on companies that the investment bank was taking to market. Andrew understands the importance of assisting Management during the sale process, which can be disruptive to the business if not managed appropriately.Further professional experience includes time in a Big 4 audit group and TAS partner at a regional accounting firm, specializing in healthcare.
